comparemela.com
Home
Live Updates
Medigene AG Reports Full-Year 2023 Financial Results and Pro
Medigene AG Reports Full-Year 2023 Financial Results and Pro
Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
Significant corporate and scientific progress in 2023Innovations to End-to-End Platform technologies and IP portfolioPipeline additions with multiple KRAS neoantigen targetsAdvancement of lead program...
Related Keywords
New York ,
United States ,
Munich ,
Bayern ,
Germany ,
Falk Pharma Gmb ,
Pamela Keck ,
Planegg Martinsried ,
Hongsheng Sciences ,
National Cancer Institute ,
Us National Cancer Institute ,
End To Platform ,
Prime Standard ,
Falk Pharma Gmbh ,
Chief Executive Officer ,
Natural Killer ,
Cancer Institute ,
Conference Call ,
Markets ,